Hormone replacement therapy

Bio-HRT options and alternatives — References & further reading

¹ Davis, P. 2008. Use of oral contraceptives and postmenopausal hormone replacement: Evidence on risk of stroke. Curr. Treat. Options Neurol., 10 (6), 468–74. URL (abstract): http://www.ncbi.nlm.nih.gov/pubmed/18990315 (accessed 02.23.2009).

  Shapiro, S. 2008. Oral contraceptives, hormone therapy and cardiovascular risk. Climacteric, 11 (5), 355–363. URL: (abstract): http://www.ncbi.nlm.nih.gov/pubmed/18781479 (accessed 02.23.2009).

  Grodstein, F., et al. 2008. Postmenopausal hormone therapy and stroke: Role of time since menopause and age at initiation of hormone therapy. Arch. Intern. Med., 168 (8), 861–866. URL (abstract): http://www.ncbi.nlm.nih.gov/pubmed/18443262 (accessed 02.23.2009).

² Hedrick, R., et al. 2009. Transdermal estradiol gel 0.1% for the treatment of vasomotor symptoms in postmenopausal women. Menopause, 16 (1), 132–140. URL (abstract): http://www.ncbi.nlm.nih.gov/pubmed/18971794 (accessed 02.06.2009).

³ Sites, C. 2008. Bioidentical hormones for menopausal therapy, p. 8: Use of bioidentical progesterone. URL: http://www.medscape.com/viewarticle/571299_8 (accessed 02.09.2009).

 

Return to:

Bioidentical hormone replacement therapy — a guide to your options and alternatives

 

Original Publication Date: 02/27/2009
Last Modified: 08/17/2009
Principal Author: Marcella Sweet